These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 19116938

  • 1. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [Abstract] [Full Text] [Related]

  • 4. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 5. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
    Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM.
    J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
    [Abstract] [Full Text] [Related]

  • 6. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [Abstract] [Full Text] [Related]

  • 7. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
    Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.
    Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093
    [Abstract] [Full Text] [Related]

  • 8. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456].
    Forsblad d'Elia H, Christgau S, Mattsson LA, Saxne T, Ohlsson C, Nordborg E, Carlsten H.
    Arthritis Res Ther; 2004 Mar; 6(5):R457-68. PubMed ID: 15380045
    [Abstract] [Full Text] [Related]

  • 9. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S.
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [Abstract] [Full Text] [Related]

  • 10. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K, Kawakami A, Tamai M, Uetani M, Takao S, Arima K, Iwamoto N, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K.
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [Abstract] [Full Text] [Related]

  • 11. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC.
    J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
    [Abstract] [Full Text] [Related]

  • 12. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E.
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [Abstract] [Full Text] [Related]

  • 13. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis.
    Oestergaard S, Chouinard L, Doyle N, Smith SY, Tankó LB, Qvist P.
    Arthritis Rheum; 2006 Sep; 54(9):2886-90. PubMed ID: 16947421
    [Abstract] [Full Text] [Related]

  • 14. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [Abstract] [Full Text] [Related]

  • 15. Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study.
    van Vulpen LF, van Meegeren ME, Roosendaal G, Jansen NW, van Laar JM, Schutgens RE, Mastbergen SC, Lafeber FP.
    Osteoarthritis Cartilage; 2015 Jan; 23(1):63-9. PubMed ID: 25219667
    [Abstract] [Full Text] [Related]

  • 16. Effects of moving training on histology and biomarkers levels of articular cartilage.
    Qi C, Changlin H.
    J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
    [Abstract] [Full Text] [Related]

  • 17. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses.
    Fradette ME, Céleste C, Richard H, Beauchamp G, Laverty S.
    Am J Vet Res; 2007 Feb; 68(2):128-33. PubMed ID: 17269876
    [Abstract] [Full Text] [Related]

  • 18. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
    Manon-Jensen T, Karsdal MA, Nielsen LN, Kjelgaard-Hansen M, Vandahl B, Olsen EH, Enoksson M, Roepstorff K.
    J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
    [Abstract] [Full Text] [Related]

  • 19. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC, Chevrel G, Schott AM, Garnero P.
    Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
    [Abstract] [Full Text] [Related]

  • 20. Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats.
    Tomiya M, Fujikawa K, Ichimura S, Kikuchi T, Yoshihara Y, Nemoto K.
    Bone; 2009 Feb; 44(2):295-305. PubMed ID: 19000792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.